Global

Elsevier,

Water Treatment Using Engineered Carbon Nanotubes, Micro and Nano Technologies series, 2024, Pages 63-96

Aligns with Goals 12 and 13 by describing the role of carbon-based materials in water treatment, the challenges to progress, and the future of these carbon-based materials in this field.

The energy transition will require new technology for clean energy. Many of those technologies require the use of critical metals which are nonrenewable and must be used responsibly and sustainably.

This content aligns with Goal 3: Good Health by discuss efficient care pathways including the optimal referral and assessment process, helpful interventions and gaps in the evidence base, and successful coordination between different mental health teams and other agencies.

Focusing on carbon capture, utilization, and storage (CCUS) technologies, this piece underscores their significance in realizing sustainability and carbon neutrality goals, particularly within challenging sectors.

Steroidal alkaloids from bioactive sources as a potential therapeutic approach to managing Alzheimer’s. It is a review, but I think it shines a really unique light in underexplored, and oft inexpensive, approaches.
2024 HPCC Systems Community Summit

The 11th annual HPCC Systems Community Summit will kick off the week of October 7 with an exciting line up of speakers, sessions and engaging workshops. This year’s theme is Igniting Innovation and is free to attend for academia, industry and technologists. The purpose of the Summit is to gather engineers, data scientists and technology professionals to share knowledge and future roadmap plans for the open source HPCC Systems platform.

The study investigates the neuroprotective effects of hordenine against AlCl3-induced Alzheimer’s disease in rats. Results show that hordenine improves memory and cognitive functions, suggesting its potential to reverse oxidative stress and neuroinflammation associated with Alzheimer’s
Nurse practitioners and other health care providers can play a crucial role in implementing chronic disease management strategies and educating patients who are at risk for AD among African Americans and Hispanics.
The study demonstrates that the peptide PHDP5, which inhibits dynamin-MT interaction, can rescue impaired endocytosis and synaptic transmission caused by tau in presynaptic terminals. When administered intranasally to Alzheimer's disease (AD) model mice, PHDP5 significantly improved learning and memory, suggesting its potential as a candidate for human AD therapy.
Despite significant investment, effective treatments for Alzheimer's disease (AD) have been elusive, necessitating improved quality and reproducibility of foundational laboratory evidence; to address this, AD-SOLES, an integrated workflow of automated tools and a publicly accessible interactive dashboard, has been developed to collect, curate, and visualize in vivo experimental evidence, enhancing evidence synthesis, tracking reporting quality, and aiding researchers in locating relevant data.

Pages